CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers.

12p13.33 micro-deletion CACNA1C CGH array Expressive language defects Visual-motor integration delay

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 03 07 2019
revised: 16 12 2019
accepted: 11 01 2020
pubmed: 19 1 2020
medline: 1 1 2021
entrez: 19 1 2020
Statut: ppublish

Résumé

We identified a de novo 44.7 Kb interstitial 12p13.33 micro-deletion that involves solely the first exon of the CACNA1C (MIM 114205), using microarray-based comparative genomic hybridization (aCGH). The associated main phenotype is characterized by expressive language impairment, tremors, fine motor-skills delay, muscular hypotonia, and joint laxity. A careful comparison between the clinical and genomic characteristics between our proband and 20 previously reported patients, led us to propose CACNA1C haploinsufficiency as the main cause of both expressive language delay and motor-skills impairment. Pathogenic variants of CACNA1C have been associated to a plethora of clinical phenotypes, such as Timothy syndrome (TS, OMIM 601005), Brugada syndrome (BRGDA3, OMIM 611875) and a variety of neuropsychiatric disorders (bipolar disorder, major depression, schizophrenia, autism spectrum disorder, psychotic manifestations). In this report we describe a 12p13.33 micro-deletion involving one coding gene only, in contrast with previous studies that mostly concluded that a multi-genes deletion in the 12p13.33 sub-telomeric region is responsible of the minimum clinical phenotype of patients with 12p13.33 monosomy. Certainly, larger deletions spanning multiple Mb in 12p13.33 are responsible for more severe phenotypes, associated to a variable degree of dysmorphic features.

Identifiants

pubmed: 31953239
pii: S1769-7212(19)30454-9
doi: 10.1016/j.ejmg.2020.103843
pii:
doi:

Substances chimiques

CACNA1C protein, human 0
Calcium Channels, L-Type 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103843

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflict of interest.

Auteurs

Catia Mio (C)

Department of Medicine (DAME), University of Udine, 33100, Udine, Italy. Electronic address: catia.mio@uniud.it.

Nadia Passon (N)

Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Federica Baldan (F)

Department of Medicine (DAME), University of Udine, 33100, Udine, Italy.

Elisa Bregant (E)

Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Elisabetta Monaco (E)

Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Loretta Mancini (L)

Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Eliana Demori (E)

Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Giuseppe Damante (G)

Department of Medicine (DAME), University of Udine, 33100, Udine, Italy; Institute of Medical Genetics, ASUIUD University Hospital of Udine, 33100, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH